15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Immunocore Holdings Ltd, 5 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $33.00 to $100.00 (about 3.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $55.50 sits 61% above the current $34.38. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.19 next quarter toward $-0.75 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy556%
Hold444%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Immunocore Holdings Ltd.
As of Sep, 5 of 8 firms rate IMCR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IMCR EPS & revenue forecast
EPS · NEXT QUARTER
$-0.19
Range $-0.53 – $0.09 · 13 analysts · -69% YoY
Next period, 13 analysts expect Immunocore Holdings Ltd to earn $-0.19 a share (range $-0.53 – $0.09), versus $-0.60 a year earlier. Full-year consensus is $-0.05, growing to $-0.75 the year after.
REVENUE · NEXT QUARTER
$116.1M
Range $109.0M – $127.0M · 13 analysts · +11% YoY
Revenue is expected to reach $116.1M (range $109.0M – $127.0M), +11.1% year-over-year. Full-year consensus is $451.7M, rising to $489.2M next year.
Top analysts covering Immunocore Holdings Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IMCR.
#1
Michael Schmidt
Guggenheim · Rank #2
Hold
No targeton IMCR
Overall win rate
55%
+ Follow
#2
Jessica Fye
JP Morgan · Rank #71
Buy
$50.00+45.4% to target
Overall win rate
53%
+ Follow
#3
Patrick R. Trucchio
HC Wainwright & Co. · Rank #230
Buy
$100.00+190.9% to target
Overall win rate
36%
+ Follow
#4
Jeff Jones
Oppenheimer · Rank #247
Buy
$86.00+150.1% to target
Overall win rate
31%
+ Follow
#5
Gil Blum
Needham · Rank #340
Buy
$75.00+118.2% to target
Overall win rate
26%
+ Follow
IMCR stock forecast FAQ
What is IMCR's average 12-month price target?+
The 8 analysts with a live target average $55.50 for Immunocore Holdings Ltd over the next 12 months, ranging from a $100.00 high to a $33.00 low.
Is IMCR stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 5 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for IMCR?+
The Street-high target is $100.00 (HC Wainwright & Co.), and the Street-low is $33.00 (Jefferies). The average of all 8 active targets is $55.50.
How many Wall Street analysts cover IMCR?+
9 analysts have an active rating on Immunocore Holdings Ltd, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering IMCR?+
Among analysts who currently cover IMCR, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #2). Their current call is Hold.
What is Immunocore Holdings Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.19 per share (range $-0.53 – $0.09) across 13 analysts. Full-year EPS is projected at $-0.05, rising to $-0.75 the following year.
How much revenue is Immunocore Holdings Ltd expected to report next quarter?+
Consensus revenue is $116.1M (range $109.0M – $127.0M). Full-year revenue is projected at $451.7M, growing to $489.2M next year.
Have analysts been upgrading or downgrading IMCR lately?+
As of Sep, 5 of 8 firms rate IMCR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IMCR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
